-- The largest shareholder in Bayer, Fonds Union, is discontent with lack of initiative from Supervisory Board chief Norbert Winkeljohann in regards to a spin-off of the company's consumer-health unit, German business paper WirtschaftsWoche reports.

-- Mr. Winkeljohann is seeking dialogue with investors, but he should have pushed more, as chief comptrollers at other companies such as Novartis or GSK are much more engaged to create value for shareholders, Portfolio Manager of Union Investment Markus Manns told the paper in an interview.

-- "It would definitely have been a matter for the board of directors to help initiate a spin-off of consumer health," Mr. Manns said in the interview.

Full story (in German): https://bit.ly/3Hoxbt3

Write to Christian Moess Laursen at christian.moess@wsj.com

(END) Dow Jones Newswires

January 23, 2023 04:34 ET (09:34 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Bayer
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Bayer